Pharmacogenetic testing by polymorphic markers G1846A...

  • Main
  • 2018 / 10
  • Pharmacogenetic testing by polymorphic markers G1846A...
Drug Metabolism and Personalized Therapy 2018 / 10

Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA)

Fedorinov, Denis S., Mirzaev, Karin B., Mustafina, Violetta R., Sychev, Dmitriy A., Maximova, Nadezda R., Chertovskikh, Jana V., Popova, Nyurguiana V., Tarabukina, Sardana M., Rudykh, Zoya A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Drug Metabolism and Personalized Therapy
DOI:
10.1515/dmpt-2018-0015
Date:
October, 2018
File:
PDF, 121 KB
english, 2018
Conversion to is in progress
Conversion to is failed